---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-005501"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T19:10:04.872847+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health secures up to $300M convertible note facility for Ethereum treasury strategy

## Summary
- Up to $300M in 9% senior secured convertible notes; initial $8M close on Aug 6, 2025.
- 72.5% of net proceeds to be used to acquire Ethereum (ETH) as a digital asset treasury reserve.
- Shares convertible at market-based pricing; beneficial ownership cap of 4.99% (can increase to 9.99%).
- Company must call shareholder meeting within 60 days to approve increase in authorized shares to 1.5B.
- Remaining proceeds for working capital, R&D, and U.S. manufacturing expansion; Curvature Securities placement agent.

## SEC filing metadata
- accession: 0001477932-25-005501
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793225005501/0001477932-25-005501-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793225005501/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-005501
- JSON: https://secwatch.observer/filing/0001477932-25-005501.json
- Plain text: https://secwatch.observer/filing/0001477932-25-005501.txt

## Key facts
- Debt Financings
  Cosmos Health Inc. incurred convertible notes of $300,000,000 with an institutional investor at 9% per annum maturing twenty four (24) months after its respective issuance date.
  - Instrument: convertible notes
  - Principal: $300,000,000
  - Counterparty: an institutional investor
  - Rate: 9% per annum
  - Maturity: twenty four (24) months after its respective issuance date
  - Event: incurrence
  source text: the Company agreed to issue and sell to the Purchaser a series of 9% original issue discount senior secured convertible promissory notes (each, a “ Note ” and collectively, the “ Notes ”) in the maximum aggregate principal amount of $300,000,000 (the “ Note Offering ”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793225005501/0001477932-25-005501-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.